Unitree IPO Creates the First Public Valuation Benchmark for Humanoid Robots
Unitree Robotics has set August 10 as the subscription date for its IPO on Shanghai's STAR Market, handing the humanoid robotics sector its first public valuation benchmark. The Hangzhou-based company aims to raise about 4.2 billion yuan, roughly $618 million, at an implied valuation near 42 billion yuan ($5.9 billion). The Unitree IPO will be the first time a profitable, scaled humanoid robot maker trades publicly.
Unitree reported $235 million in revenue for 2025 with gross margins around 60%, a profile that separates it from most of the industry. The company is profitable, which is rare in a sector where many peers are still years away from positive cash flow. Growth is cooling, however: first-half revenue rose 40%, a step down from the steep ramp of the previous year as competition across China's robotics sector intensifies.
The First Public Price Tag for Humanoid Robots
The listing makes Unitree the first humanoid robot company in the history of China's A-share market. Its application cleared regulatory review in a record 104 days, and the securities regulator approved registration earlier this month, a pace that reflects official support for the sector as much as the rush among Chinese robot makers to list. The schedule is tight: preliminary price inquiry runs on August 5, online and offline subscriptions open together on August 10, and payment is due by August 12. The trading debut date has not been disclosed.
The price is what makes the deal a milestone. Unitree is coming to market at roughly 42 billion yuan against $235 million of 2025 revenue, an implied multiple of about 25 times trailing sales. Across the Pacific, Figure AI has raised private capital at a $39 billion valuation with no revenue to show for it. The two numbers frame the gap between China's revenue-generating robot builders and Western peers still funding development with investor money.
| Metric | Unitree Robotics | Figure AI |
|---|---|---|
| 2025 revenue | $235 million | None disclosed |
| Gross margin | About 60% | Not disclosed |
| Profitability | Profitable | Not disclosed |
| 2025 robot shipments | 5,500+ | Not disclosed |
| Latest valuation | About 42 billion yuan ($5.9 billion) at IPO | $39 billion, private |
Unitree's edge is operational: it ships humanoid and quadruped robots in volume and sells them, which is more than most Western humanoid startups can claim. The company built its name on quadruped robots before moving into humanoids, a product mix that gives it a second revenue line most rivals lack. Figure's valuation rests on its technical progress and funding history rather than on shipments. The market is now being asked, for the first time, to price those two models against each other in real time.
What the Unitree IPO Puts at Risk
The offering carries a geopolitical overhang that the prospectus addresses directly. Unitree flagged US sales risk ahead of the listing, citing trade restrictions and regulatory measures aimed at the robotics sector. In July 2026 the US Federal Communications Commission blocked new Chinese humanoid robots and power inverters from the US market, a decision that narrows Unitree's addressable market at a delicate moment for its fundraising narrative. The IPO is in effect a test of whether investors believe the company can grow around that wall.
Unitree is answering with a bet on technology independence. The roughly 4.2 billion yuan raised is earmarked for embodied intelligence model research, robot hardware development, and a new manufacturing base. That allocation signals confidence that domestic demand and export markets beyond the US can absorb the growth the restrictions take away, and it doubles as a statement of intent about building the full stack in China.
Chinese investors have already shown how they read the story. Registration approval triggered a wave of limit-up moves across A-share humanoid robot stocks, and ETF issuer KraneShares has framed the listing as expanding the investable universe for humanoid robotics funds while giving the sector a daily-priced valuation benchmark. The plumbing matters as much as the price: once trading starts, index and ETF mechanics will track Unitree, pulling fund flows into the stock automatically and adding its valuation to the benchmarks institutional investors already track.
Unitree is not alone at the gate. A string of Chinese robotics startups have filed or signaled plans to go public, riding the same wave of policy support and investor enthusiasm. The cluster of listings means the first benchmark will not be the last: each debut will be priced against Unitree's multiple, and the comparison will discipline valuations across the group rather than leaving each company to set its own story.
From Hype to Earnings Validation
The Unitree IPO lands at a moment when the sector is shifting from hype to earnings validation. Unitree's financials give the shift a concrete reference: a profitable maker with 60% gross margins and more than 5,500 robots shipped in 2025. At the same time, the slowdown to 40% first-half growth means the multiple will be tested against a decelerating trajectory, and any miss on delivery volumes will hit the stock in a way that private funding rounds never exposed.
Western competitors face a direct consequence in their next funding round. Private investors will now have a public comparable to anchor against: a company that sells robots profitably at a roughly 25-times-revenue multiple. Any US or European startup asking for a higher multiple will need to justify the gap with something more than a roadmap, a discipline the sector has not had to face.
The Verdict
The benchmark cuts in both directions. A strong debut would validate the revenue-first model Chinese builders have pursued, while a weak one would support the argument that humanoid valuations run ahead of fundamentals. The listing also replaces private rounds as the sector's valuation filter, moving price-setting from closed-door negotiations to a daily public auction. Unitree's own risk disclosures (US trade restrictions, slower growth, tougher domestic competition) are the same pressures facing the wave of Chinese robotics startups now pursuing listings of their own.
For decision-makers, the practical read is to watch subscription demand and first-day trading rather than the headline number. The 42 billion yuan reference point is the sector's first daily-priced marker, and how it holds will shape pricing for the next round of robot IPOs in China and the fundraising expectations of private rivals abroad.
Why this matters
The Unitree IPO turns a hype-driven category into a measurable one. Investors can now price a profitable humanoid robot maker against real revenue, and that number becomes the reference for every rival that follows. For US players such as Figure AI, the contrast is uncomfortable: a $39 billion valuation with no revenue sits beside a $5.9 billion company that shipped more than 5,500 robots last year. That benchmark will reset expectations on both sides of the Pacific.
Related Articles
- Humanoid Robotics IPO Hype Masks Unitree Profit Crisis
- Unitree Debuts H2 Plus as First Reference Hardware for NVIDIA Isaac GR00T Humanoid AI Platform
- Humanoid Becomes Europe's First Humanoid Robotics Unicorn with $152M Series A
✔Human Verified
Researched and cross-referenced against primary sources by the Bytevyte editorial team. This article was generated with the assistance of artificial intelligence and reviewed by the Bytevyte editorial team.